Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality
JACC: Advances · 2026-08 · 5 (8) · 103019
DOI: 10.1016/j.jacadv.2026.103019 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Advances, 2026-08. Verfasst von Gabriela Spencer-Bonilla und 13 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, AstraZeneca.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CM) is a progressive, underdiagnosed cause of heart failure (HF). Diagnostic delays may increase cardiac injury at treatment initiation, but the relationship between delay and outcomes remains poorly defined. OBJECTIVES: The purpose of this study was to evaluate time from HF diagnosis to ATTR-CM diagnosis as a proxy for disease progression and its association with HF hospitalization (HFH) and mortality. METHODS: This retrospective cohort study used Medicare fee-for-service and Veterans Health Administration (VHA) data. We identified patients diagnosed with ATTR-CM between 2016 and 2022 using a validated algorithm based on diagnoses and medications. Time-to-diagnosis was defined as days between each patient's first HF diagnosis and first amyloid diagnosis. Using multivariable Cox models, we evaluated its association with death or HFH. RESULTS: We identified 7,770 Medicare beneficiaries and 2,557 Veterans with HF and ATTR-CM. Median age at diagnosis was 81 years in both cohorts (Medicare IQR: 76-86; VHA IQR: 74-87); women comprised 1,775 (22.8%) of Medicare and 13 (0.5%) of VHA patients. Median time-to-diagnosis was 494 days (IQR: 63-1,340) for Medicare and 490 days (IQR: 69-1,286) for VHA. After adjustment for sociodemographics, each 1-year delay was associated with a 7% increased risk of the primary outcome (Medicare HR: 1.07; 95% CI: 1.06-1.08; VHA HR: 1.07; 95% CI: 1.05-1.09). Results were similar after adjusting for comorbidities. CONCLUSIONS: Across 2 real-world populations, diagnostic delay in ATTR-CM is a clinically meaningful marker of disease progression, with longer delays associated with increased HFH and mortality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
- Veteran's Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
- U.S. Medical Affairs, BioPharmaceutical Medical, AstraZeneca, Wilmington, Delaware, USA.
- Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA; Veteran's Affairs Palo Alto Healthcare System, Palo Alto, California, USA.
- Division of Cardiology, Department of Medicine, University of California-Los Angeles, Los Angeles, California, USA; Greater Los Angeles VA Healthcare System, Los Angeles, California, USA. Electronic address: atsandhu@me…
Förderung
- NHLBI NIH HHS
- AstraZeneca
Zitieren
APA
Spencer-Bonilla, G., Fan, J., Varshney, A. S., Cheng, P., Din, N., Rodriguez, F., Davies, M., Papas, M. A., Huang, J., Venditto, J., Witteles, R. M., Heidenreich, P., Alexander, K., & Sandhu, A. T. (2026). Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality. JACC: Advances, 5(8), 103019. https://doi.org/10.1016/j.jacadv.2026.103019
Vancouver
Spencer-Bonilla G, Fan J, Varshney AS, Cheng P, Din N, Rodriguez F, et al. Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality. JACC: Advances. 2026;5(8):103019. doi:10.1016/j.jacadv.2026.103019
BibTeX
@article{SpencerBonilla2026,
author = {Spencer-Bonilla, Gabriela and Fan, Jun and Varshney, Anubodh Sunny and Cheng, Paul and Din, Natasha and Rodriguez, Fatima and Davies, Marie and Papas, Mia A and Huang, Joanna and Venditto, John and Witteles, Ronald M and Heidenreich, Paul and Alexander, Kevin and Sandhu, Alexander T},
title = {Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality},
journal = {JACC: Advances},
year = {2026},
volume = {5},
number = {8},
pages = {103019},
doi = {10.1016/j.jacadv.2026.103019}
}
EUVIMED